What if cancer drugs could enter the brain naturally? This research shows how HER3-guided nanobioparticles make it possible.
End of Content.
Get the latest creative news from us about politics, business, sport and travel
End of Content.
Lali Medina-Kauwe, PhD, is a molecular engineer with expertise in creating tumor-targeted nanobiologics. She is an inventor on >35 national and international patents and has contributed expertise toward two start-up biotech companies. She holds the Carol Moss Foundation Endowed Chair in Medical Discovery and is Associate Director of Cancer Basic Research at Cedars-Sinai Medical Center. She is also the Associate Dean of PhD programs at Cedars-Sinai’s Health Sciences University and directs the PhD program in Biomedical and Translational Sciences. Her research has been supported by the NIH/NCI, the Department of Defense, the Avon Foundation, the Komen foundation, and other sources.

Lali Medina-Kauwe, PhD, is a molecular engineer with expertise in creating tumor-targeted nanobiologics. She is an inventor on >35 national and international patents and has contributed expertise toward two start-up biotech companies. She holds the Carol Moss Foundation Endowed Chair in Medical Discovery and is Associate Director of Cancer Basic Research at Cedars-Sinai Medical Center. She is also the Associate Dean of PhD programs at Cedars-Sinai’s Health Sciences University and directs the PhD program in Biomedical and Translational Sciences. Her research has been supported by the NIH/NCI, the Department of Defense, the Avon Foundation, the Komen foundation, and other sources.
What if cancer drugs could enter the brain naturally? This research shows how HER3-guided nanobioparticles make it possible.